CNXU
Conexeu Sciences Inc.
Going-concern doubt
— flagged Jun 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“During the three months ended April 30, 2026, and 2025, the Company recorded a net loss of $2,304,283 and $458,050, respectively. During the six months ended April 30, 2026, and 2025, the Company recorded a net loss of $4,023,106 and $748,114, respectively. As of April 30, 2026, and October 31, 2025, the Company had an accumulated deficit of $8,544,626 and $4,521,520, respectively. These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of these unaudited condensed interim financial statements being issued.”View the 10-Q filed Jun 15, 2026
Company with tickers: CNXU
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-06-30 | New | Biotechnology | $86,320 | $86,320 | 06b |
| 2026-06-30 | New | Biotechnology | $465,953 | $203 | 06b |
| 2026-06-12 | Amendment | Biotechnology | $2,200 | $1,700 | 06b |
| 2026-06-10 | New | Biotechnology | $137,427 | $22,905 | 06b |
| 2026-05-21 | New | Biotechnology | $44,700 | $44,700 | 06b |
| 2026-05-21 | New | Biotechnology | $1,248,634 | $543 | 06b |
| 2026-04-01 | New | Biotechnology | $1,815,000 | $1,815,000 | 06b |
| 2026-03-23 | New | Biotechnology | $44,698 | $44,698 | 06b |
| 2026-02-27 | New | Biotechnology | $1,072,437 | $467 | 06b |
| 2026-02-04 | New | Biotechnology | $810,000 | $810,000 | 06b |
| 2025-11-20 | New | Biotechnology | $202,299 | $202,299 | 06b |
| 2025-11-13 | New | Biotechnology | $2,921,446 | $2,921,446 | 06b |
| 2025-07-02 | Amendment | Biotechnology | $2,531,964 | $1,287,329 | 06b |
| 2025-06-13 | New | Biotechnology | $2,200 | $1,200 | 06b |
| 2025-05-09 | New | Biotechnology | $2,411,964 | $1,287,329 | 06b |
Showing 1–15 of 15 filings